Puma Biotechnology (PBYI) Stock Statistics & Valuation Metrics

Puma Biotechnology has a market cap or net worth of $402.11M. The enterprise value is $347.76M.

Puma Biotechnology has 50,899,456 shares outstanding. The number of shares has decreased by -2.65% in one year.

Puma Biotechnology’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 20.41%.

The current PE Ratio of Puma Biotechnology is 16.1. Puma Biotechnology’s PEG ratio is 0.00.

In the last 12 months, Puma Biotechnology had revenue of 228.37M and earned 31.11M in profits. Earnings per share was 0.62.

In the last 12 months, operating cash flow was 53.61M and capital expenditures -10.00K, giving a free cash flow of 53.60M billion.

Puma Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―

Puma Biotechnology upcoming earnings date is Jul 30, 2026, After Close (Confirmed).

Puma Biotechnology as a current ratio of 2.00, with Debt / Equity ratio of 12.42%

In the past 12 months, Puma Biotechnology has paid 4.67M in taxes.

Puma Biotechnology EV to EBITDA ratio is 5.56, with an EV/FCF ratio of 7.10.

Puma Biotechnology has $101.55M in cash and marketable securities with $15.95M in debt, giving a net cash position of $85.59M billion.

Gross margin is 74.46%, with operating margin of 16.33%, and net profit margin of 13.62%.

The average price target for Puma Biotechnology is $5.00, which is 11.43% higher than the current price. The consensus rating is Hold